Advances in oral anticoagulation treatment: the safety and efficacy of rivaroxaban in the prevention and treatment of thromboembolism

Por Turpie, Alexander G.G.
Publicado em 2012

New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins

Por Ageno, Walter, Turpie, Alexander G.G.
Publicado em 2002

Prevention of venous thromboembolism in medically ill patients: a clinical update

Por Turpie, Alexander G G, Leizorovicz, Alain
Publicado em 2006

Real-world data confirm clinical trial outcomes for rivaroxaban in orthopaedic patients

Por Kwong, Louis, Turpie, Alexander G.G.
Publicado no Curr Orthop Pract (2015)

Outpatient thromboprophylaxis after hip or knee surgery: discrepancies and concerns

Por Fisher, William D., Turpie, Alexander G.G.
Publicado em 2008

Valvar heart disease and prosthetic heart valves

Por Goldsmith, Ira, Turpie, Alexander G G, Lip, Gregory Y H
Publicado em 2002

Venous thromboembolism: pathophysiology, clinical features, and prevention

Por Turpie, Alexander G G, Chin, Bernard S P, Lip, Gregory Y H
Publicado em 2002

Venous thromboembolism: treatment strategies

Por Turpie, Alexander G G, Chin, Bernard S P, Lip, Gregory Y H
Publicado em 2002

Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions

Por Kreutz, Reinhold, Haas, Sylvia, Holberg, Gerlind, Lassen, Michael R., Mantovani, Lorenzo G., Schmidt, André, Turpie, Alexander G. G.
Publicado no Br J Clin Pharmacol (2016)

XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation

Por Camm, A. John, Amarenco, Pierre, Haas, Sylvia, Hess, Susanne, Kirchhof, Paulus, Kuhls, Silvia, van Eickels, Martin, Turpie, Alexander G.G.
Publicado no Eur Heart J (2016)

Approach to managing musculoskeletal pain: Acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs?

Por Hunt, Richard H., Choquette, Denis, Craig, Brian N., De Angelis, Carlo, Habal, Flavio, Fulthorpe, Gordon, Stewart, John I., Turpie, Alexander G.G., Davis, Paul
Publicado em 2007

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

Por Cohen, Alexander T, Davidson, Bruce L, Gallus, Alexander S, Lassen, Michael R, Prins, Martin H, Tomkowski, Witold, Turpie, Alexander G G, Egberts, Jan F M, Lensing, Anthonie W A
Publicado em 2006

Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model

Por Goldenberg, Neil A., Spyropoulos, Alex C., Halperin, Jonathan L., Kessler, Craig M., Schulman, Sam, Turpie, Alexander G. G., Skene, Allan M., Cutler, Neal R., Hiatt, William R.
Publicado em 2011

Balancing Risk and Benefit in Venous Thromboembolism Trials: Concept for a Bivariate Endpoint Trial Design and Analytic Approach

Por Kittelson, John M., Spyropoulos, Alex C., Halperin, Jonathan L., Kessler, Craig M., Schulman, Sam, Steg, Gabriel, Turpie, Alexander G. G., Cutler, Neal R., Hiatt, William R., Goldenberg, Neil A.
Publicado no J Thromb Haemost (2013)

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation

Por Douketis, James D., Spyropoulos, Alex C., Kaatz, Scott, Becker, Richard C., Caprini, Joseph A., Dunn, Andrew S., Garcia, David A., Jacobson, Alan, Jaffer, Amir K., Kong, David F., Schulman, Sam, Turpie, Alexander G.G., Hasselblad, Vic, Ortel, Thomas L.
Publicado no N Engl J Med (2015)

Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective G...

Por Kakkar, Ajay K., Mueller, Iris, Bassand, Jean-Pierre, Fitzmaurice, David A., Goldhaber, Samuel Z., Goto, Shinya, Haas, Sylvia, Hacke, Werner, Lip, Gregory Y. H., Mantovani, Lorenzo G., Turpie, Alexander G. G., van Eickels, Martin, Misselwitz, Frank, Rushton-Smith, Sophie, Kayani, Gloria, Wilkinson, Peter, Verheugt, Freek W. A.
Publicado em 2013

Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF

Por Bassand, Jean-Pierre, Accetta, Gabriele, Camm, Alan John, Cools, Frank, Fitzmaurice, David A., Fox, Keith A.A., Goldhaber, Samuel Z., Goto, Shinya, Haas, Sylvia, Hacke, Werner, Kayani, Gloria, Mantovani, Lorenzo G., Misselwitz, Frank, ten Cate, Hugo, Turpie, Alexander G.G., Verheugt, Freek W.A., Kakkar, Ajay K.
Publicado no Eur Heart J (2016)

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

Por Camm, A John, Accetta, Gabriele, Ambrosio, Giuseppe, Atar, Dan, Bassand, Jean-Pierre, Berge, Eivind, Cools, Frank, Fitzmaurice, David A, Goldhaber, Samuel Z, Goto, Shinya, Haas, Sylvia, Kayani, Gloria, Koretsune, Yukihiro, Mantovani, Lorenzo G, Misselwitz, Frank, Oh, Seil, Turpie, Alexander G G, Verheugt, Freek W A, Kakkar, Ajay K
Publicado no Heart (2017)

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry

Por Haas, Sylvia, ten Cate, Hugo, Accetta, Gabriele, Angchaisuksiri, Pantep, Bassand, Jean-Pierre, Camm, A. John, Corbalan, Ramon, Darius, Harald, Fitzmaurice, David A., Goldhaber, Samuel Z., Goto, Shinya, Jacobson, Barry, Kayani, Gloria, Mantovani, Lorenzo G., Misselwitz, Frank, Pieper, Karen, Schellong, Sebastian M., Stepinska, Janina, Turpie, Alexander G. G., van Eickels, Martin, Kakkar, Ajay K.
Publicado no PLoS One (2016)